Macro Overview of the Uterus
The mammalian uterus is a complex reproductive organ whose primary purpose is to support the implanted embryo/fetus throughout gestation. It undergoes four main developmental programs over the course of a lifetime.
The first program establishes the simple uterine tube. In mice this tube forms in the absence of estrogen receptors (ER) 1 or progesterone receptors (PR), 2 indicating that the early program acts independently of the steroid hormones estradiol or progesterone. The second program begins with the onset of puberty, as the endometrium undergoes cyclical waves of proliferation, differentiation, and, barring implantation, regression; this cyclic wave is termed the menstrual cycle in primates and estrous cycle in nonprimate species. In preparation for implantation of the embryo into the uterine lining, the third program begins with decidualization induced by progesterone signaling. 3 This process causes increased glandular cell secretions, vascular remodeling,
Wnt/ß-catenin/Lef-1 signaling in the uterus
2 and stromal storage of glycogen. These changes support the developing embryo until the placenta matures as well as modulate maternal-fetal communications. Finally, as the ovaries stop producing estradiol, testosterone, and progesterone, the uterus regresses into a state of atrophy and a woman enters menopause. While the roles of estrogen, progesterone, and testosterone in these programs have been widely studied, the molecular mechanisms determining initial development, adenogenesis, and regeneration of the endometrium are still unclear.
Molecular/histological description of the uterus and stages of development
The uterus consists of a highly regenerative endometrium and a muscular outer myometrium. 4 The endometrium is made up of the luminal epithelium and tree-like endometrial glands, which are embedded within a fibroblast-like stroma. In humans the endometrium is further divided into the basalis layer of tissue and epithelial glands. The Basalis layer consists of a dense stroma near the myometrium and is interspersed with epithelial glands, in which reside the putative adult stem cells needed to regenerate the endometrium following menses.
5,6,7 These stem cells reepithelialize the lumen, and then expand the stromal and glandular portions to reform the functionalis layer. Though histologically distinct in humans, these layers appear less well defined in mice. However, studies examining label-retaining cells (LRCs) in the murine endometrium following decidualization and endometrial breakdown during the estrous cycle indicate the existence of putative stem cells near the myometrial layer in the remnants of endometrial glands. 8 The uterus is derived from the sexually undistinguished bilateral embryonic Mullerian ducts, which are formed during invagination of the coelomic epithelium into tubular stoma.
9 Expression of the maledetermining factor, SRY, stimulates expression of antiMullerian hormone (AMH), which induces regression of the Mullerian duct in males. Without SRY and AMH, the Mullerian ducts continue developing and eventually become the female internal reproductive organs. 10 As the ducts proliferate and expand caudally, the Mullerian ducts fuse at the midline, thus forming the uterus. In primates this fusion is complete and yields a single uterus, whereas in most nonprimate mammals incomplete fusion occurs and leads to the presence of two uterine horns. While development of the uterus is wellunderstood at the anatomical level, we are still unraveling the cellular pathways that mediate these distinct stages of development. However, several pieces of data have demonstrated a critical role for the Wnt signaling pathway in formation of the uterus. 
Indications that the Wnt pathway is critical to uterine development

Wnt pathway overview
The Wnt pathway was initially discovered via two parallel areas of research, early development and tumorigenesis.
In Drosophila, mutations in the Wingless (Wg) gene led to wingless flies and other early developmental abnormalities.
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Studies involving the int gene in mice revealed the role of this protein in tumorigenesis. 23 Many years later homology studies indicated that the Wg and int genes belong to the same evolutionary family, and the canonical Wnt pathway was born.
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Wnt is now known to be a secreted ligand that binds to the Frizzled (Fz) receptor family of nearby cells, often in a gradient fashion, to regulate cell differentiation and proliferation in early development. 25, 26, 27 Fz then activates the Dishevelled (Dsh) protein, which causes the disassociation of the "β-catenin destruction complex." 28, 29, 30, 31, 32 This complex of proteins consists of the adenomatous polyposis coli gene (APC), axin, and GSK3, which induce degradation of β-catenin through proteolysis. In response to a Wnt activating signal, β-catenin levels rise, and then β-catenin translocates to the cell nucleus and binds to transcription factors of the TCF/LEF family. 33, 34, 35 Thus, β-catenin serves as transcriptional activator for downstream target genes. The list of Wnt signaling targets include cyclin D, a regulator of cell cycle progression, 36, 37 c-myc, a strong oncogene that recruits histone acetyltransferases (HATs), which remodel the chromatin and allow for increased transcription, 38 Wnt/ß-catenin/Lef-1 signaling in the uterus 4
and several matrix metalloproteins (MMPs), which are involved in cell migration and differentiation. 39, 40, 41 By controlling expression of multiple genes that mediate in a plethora of cellular events, the Wnt pathway is a central regulator of basic cellular processes.
In In one study, transgenic mice in which activated β-catenin was expressed specifically in the uterus exhibited high levels of nuclear β-catenin accumulation, increased expression of c-myc and cyclin D1, increased glandular proliferation, and extensive hyperplasia -but, strikingly, no cancer within the first year of life. 16 Thus, these data suggest that elevated nuclear β-catenin alone is not tumorigenic.
Another study examined the role of Lef1 in endometrial cancer, a downstream target of β-catenin signaling (Shelton and Goodheart, submitted Clinical Cancer Research). Aberrant overexpression of the Wnt-pathway target gene LEF1 has been detected in several cancers, principally colon, leukemia, melanoma, and pancreatic. In unpublished data, we found that expression of Lef1 is also elevated in human endometrial tumors regardless of histological subtype and in non-cancerous proliferative endometrium but not in inactive endometrium. Lef1 mRNA was expressed at higher levels in EEC than in NEEC, and was expressed at higher levels in tumors of grades 1 and 2 than in those of grade 3. Importantly, Lef1 expression was higher in cohorts with good prognosis. Collectively, these data suggest a role for Lef1 in tumorigenesis but not metastasis.
In addition to Lef1 and β-catenin, we have observed significant dysregulation of several components of the Wnt pathway (Goodheart, et al, unpublished observations). Taken together with the current understanding of β-catenin and Lef1 in endometrial cancer, these data underscore the importance of Wnt signaling in not only endometrial gland formation, but also in endometrial cancer formation.
Conclusions
Wnt/β-catenin signaling appears to be important in a multitude of cancers, including endometrial cancer. Our data, detailed above, supports a role for the Wnt/β-catenin/Lef1 pathway involvement in endometrial cancer in addition to generalized gland regulation and formation (submitted Neoplasia). Many commercial pharmaceutical companies are developing targeted inhibitors of Wnt signaling, and currently there are compounds available for use in cell culture and animal experiments (e.g., XAV939 www.reagentsdirect.com).
Further investigation into the complex interactions between Wnt/β-catenin Wnt/ß-catenin/Lef-1 signaling in the uterus 7 signaling and endometrial gland formation and cancer appears to be warranted in order to selectively inhibit pathways that are integral for endometrial cancer development. 
